As of 2025-12-19, the Relative Valuation of NGM Biopharmaceuticals Inc (NGM) is (51.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.54 USD, the upside of NGM Biopharmaceuticals Inc based on Relative Valuation is -3434.4%.
The range of the Relative Valuation is (41.69) - (66.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.7x - 38.9x | 21.6x |
| Forward P/E multiples | 24.4x - 47.5x | 38.6x |
| Fair Price | (41.69) - (66.33) | (51.35) |
| Upside | -2807.4% - -4407.0% | -3434.4% |
| Date | P/E |